Detalles de la búsqueda
1.
Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD-1 therapy.
Cancer
; 129(13): 2047-2055, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37089083
2.
Diagnostic and prognostic role of long non-coding RNAs (lncRNAs) in metastatic melanoma patients with BRAF gene mutation receiving BRAF and MEK inhibitors.
Heliyon
; 10(7): e29071, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601651
3.
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.
Cancer Immunol Res
; 12(4): 427-439, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315788
4.
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy.
Cells
; 12(5)2023 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899926
5.
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients.
Cells
; 12(6)2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980196
6.
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma.
Target Oncol
; 18(2): 235-245, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906728
7.
Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment.
Melanoma Res
; 33(3): 208-217, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37015054
8.
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report.
Cancers (Basel)
; 15(17)2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686659
9.
MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression.
Front Cell Dev Biol
; 10: 1008901, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36619870
10.
A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition.
Cancers (Basel)
; 14(21)2022 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358789
11.
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.
Cancers (Basel)
; 14(9)2022 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565255
12.
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence.
J Clin Med
; 11(8)2022 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35456332
13.
Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma.
J Dermatolog Treat
; 33(4): 2168-2174, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057374
14.
The Analysis of Inflammation-Related Proteins in a Cargo of Exosomes Derived from the Serum of Uveal Melanoma Patients Reveals Potential Biomarkers of Disease Progression.
Cancers (Basel)
; 13(13)2021 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283046
15.
Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization.
Cancers (Basel)
; 13(2)2021 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33435427
16.
Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients.
Melanoma Res
; 31(1): 49-57, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165240
17.
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland.
Immunotherapy
; 13(4): 297-307, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33353420
18.
Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6.
Oncoimmunology
; 9(1): 1710063, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002306
19.
BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma.
Melanoma Res
; 30(5): 465-471, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221131
20.
Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence.
Adv Med Sci
; 65(2): 316-323, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32554313